brensocatibnon-cystic fibrosis bronchiectasisNCT04594369ASPENbronchiectasis
…analyses showed that, consistent with the phase 2 WILLOW trial, brensocatib treatment resulted in a dose-dependent reduction of NSP activit…
1articles mentioning drugs
10drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Brensocatib ×
Brensocatib
This drug is selected. Its supporting articles are shown below.